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Abstract: Autophagy is a highly regulated intracellular process involved in the turnover of 
most cellular constituents and in the maintenance of cellular homeostasis. In this study, we 
show  that  the  activity  of  autophagy  increases  in  H2O2  or  RasV12-induced  senescent 
fibroblasts. Inhibiting autophagy promotes cell apoptosis in senescent cells, suggesting that 
autophagy activation plays a cytoprotective role. Furthermore, our data indicate that the 
increase of autophagy in senescent cells is linked to the activation of transcription factor 
FoxO3A, which blocks ATP generation by transcriptionally up-regulating the expression of 
PDK4, an inhibitor of pyruvate dehydrogenase complex, thus leading to AMPK activation 
and  mTOR  inhibition.  These  findings  suggest  a  novel  mechanism  by  which  FoxO3A 
factors can activate autophagy via metabolic alteration. 
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1. Introduction 
Premature senescence occurs when cells are exposed to an oxidative or genotoxic stress that causes 
DNA damage. It also can be induced by an oncogenic stress (such as ectopic overexpression of Ras or 
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Raf by gene transfection) that results in aberrant regulation of cell proliferation. Many types of normal 
and tumor cells undergo premature senescence after exposure to H2O2, radiation, or a DNA damaging 
agent [1–3]. Premature senescent cells exhibit some of the same characteristics as replicative senescent 
cells, including permanent cell cycle arrest, enlarged and flattened cell morphology, and increased 
senescence-associated β-galactosidase (SA-β-gal) activity [1,2]. It has been suggested that senescence 
response, similar to apoptosis, is critical for suppressing tumorigenesis in complex eukaryotes [4,5]. 
Thus, genetically engineered mice comprised of cells that cannot undergo a normal senescence response 
typically die prematurely of cancer [6,7]. In contrast to apoptosis, however, cellular senescence does 
not eliminate cells that are dysfunctional, damaged or potentially neoplastic. Rather, the senescence 
response irreversibly arrests the proliferation of such cells. Thus, cellular senescence renders cells 
incapable of forming a tumor (by permanently arresting cell growth), but senescent cells may persist  
in tissues.  
Macroautophagy (hereafter referred to as autophagy) is one of the major pathways for degradation 
of  cellular  components  in  eukaryotic  cells  that  controls  the  turnover  of  long-lived  proteins  and 
organelles [8]. This evolutionary conserved process is characterized by the formation of double-membrane 
cytosolic  vesicles,  called  autophagosomes,  which  sequester  cytoplasmic  content  and  deliver  it  to 
lysosomes [9]. Although initially identified as a process induced by cellular starvation, an autophagic 
pathway  is  now  recognized  as  the  cellular  response  to  a  variety  of  stimuli  including  starvation, 
hormone  treatment,  virus  infection  and  various  stress  conditions  [10–12].  To  date,  functions  of 
autophagy are not well understood. In most circumstances, autophagy appears to promote cell survival 
by adapting cells to stress conditions. However, autophagy has also been considered as a non-apoptotic 
program of cell death that is referred to  as  ―autophagic‖ or ―type-II‖ cell death.  In some cellular 
settings,  autophagy  is  reportedly  conducive  to  cell  death  when  apoptosis  is  inhibited,  acting  as  a 
backup mechanism to execute the death process [13].  
Autophagy  activity  has  been  shown  to  increase  in  senescent  fibroblasts  [14,15];  however,  its 
function  and  regulation  in  senescent  cells  are  still  unclear.  In  this  study,  we  used  H2O2-induced 
senescent cells as a senescent model to investigate the role of autophagy activation in senescent cells. 
Our results show that autophagy is required for H2O2-induced senescence process, and inhibition of 
autophagy may result in the increase of apoptosis during cellular senescent process. These results 
indicate that autophagy plays a cyto-protective role in senescent cells. Furthermore, we show that 
FoxO3A activation contributes to the increase of autophagy activity in senescent cells via blocking 
ATP product.  
2. Results 
2.1. Autophagy Activity Increases in Stress-Induced Premature Senescent Cells 
To  determine  whether  autophagy  was  up-regulated  in  senescent  cells,  hallmarks  of  cellular 
autophagosomes were analyzed in morphological experiments in senescent cells, induced with either 
sub-lethal  concentration  of  H2O2  or  constitutively  active  RasV12.  Changes  of  autophagosome 
morphology  were  first  determined  with  MDC  staining  assay  (Figure  1A,  upper  panel).  Result  
showed  that  the  number  of  MDC-stained  punctuate  structures,  indicative  of  the  formation  of Int. J. Mol. Sci. 2012, 13 
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autophagosomes [16], was increased in both H2O2 and RasV12-induced senescent cells. Furthermore, 
the autophagic process was monitored using transmission electron microscopy (TEM), one of the most 
reliable measurements for autophagy [17]. It was observed under TEM that the number of double 
membraned  vesicles  (characteristics  of  autophagosome  formation)  in  H2O2  and  RasV12-induced 
senescent cells was significantly higher than that in young cells. The data indicated that autophagosomes 
were rarely observed in  young cells,  but  could  be readily observed in  H2O2 and RasV12-induced 
senescent cells (Figure 1A, Lower panel). Altogether, the data from fluorescence and electron microscopy 
indicated that H2O2 or RasV12-induced senescence was accompanied by elevated autophagy activity.  
Figure  1.  The  activity  of  autophagy  increased  in  senescent  cells.  (A)  Morphological 
analysis  of  autophagy  and  cellular  senescence  in  2BS  cells.  Upper  panel:  H2O2  or  
RasV12-induced senescent cells were stained with MDC. Young 2BS cells were used as a 
control. MDC-positive cells (%) were presented as the mean ±  SD from three independent 
experiments.  Lower  panel:  Young  and  senescent  cells  were  subjected  to  transmission 
electron microscopy (TEM). The arrows indicated typical autophagosomes. The number of 
autophagosome  vesicles  were  counted under one TEM  field per  cell type,  which were 
presented as the mean ±  SD from three independent experiments. Statistical significance 
was analyzed by using one-way ANOVA and Student-Newman-Keuls analysis. ** indicated 
a significant difference between senescent and control cells (P < 0.01). (B) Semiquantitative 
analysis of the expression of LC3 by immunoblotting. Densitometry was performed for 
quantification (LC3-II/actin). 
 
To further confirm the observations, immunoblotting assay was carried out to examine the protein 
expression of LC3, a specific marker for autophagy. Indeed, H2O2 or RasV12-induced senescent cells Int. J. Mol. Sci. 2012, 13 
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had a higher LC3 protein expression as compared with young cells (Figure 1B). Taken together, our 
results confirmed that autophagy activity was elevated in senescent cells. 
2.2. Blockage of Autophagy Results in Increased Apoptosis and Impaired Senescence Manifestation 
During H2O2-Induced Senescent Process 
Next,  we  examined  the  potential  effects  of  autophagy  inhibition  on  H2O2  or  RasV12-induced 
senescent process. Young cells were treated with 3-MA (1 mM) to inhibit the activity of class III 
phosphatidylinositol 3'-kinase, to prevent the formation of autophagosomes and to block autophagy [18]. 
Results showed that autophagy was evidently inhibited at day 4 after H2O2 treatment in the presence of 
3-MA, which was assessed by the number of punctuate GFP-LC3 (Figure 2A, third line). Subsequently, 
we employed flow cytometry to examine apoptosis at day 4 after H2O2 treatment where autophagy was 
inhibited by 3-MA. Four-day treatment was chosen as the observation point due to the fact that at this 
time  point  the  premature  senescence-induction  was  very  evident  in  response  to  200  μM  H2O2  as 
described in Materials and Methods. Cells containing Annexin-V-FITC were considered apoptotic. As 
shown in Figure 2A (fourth line), 3-MA treatment significantly increased apoptosis in H2O2-treated 
cells compared to control cells, suggesting that inhibition of autophagy promoted cell apoptosis when 
cells were exposed to sublethal H2O2 level. To investigate the relationship between autophagy and 
senescence, SA-β-gal assay was employed to detect senescence in 3MA treated and untreated cells, it 
was shown that autophagy was closely linked with senescence since no sign of SA-β-gal positive cells 
were shown when autophagy was blocked (Figure 2A, second line). Similar result was obtained when 
senescence was induced by RasV12 in the presence of 3-MA.  
To further confirm  the observation that inhibition of autophagy induced apoptosis  in senescent  
cells,  RNA  interference  was  used  to  deplete  Beclin  1  protein,  a  molecule  that  is  known  to  be  
necessary for autophagy and to regulate autophagic initiation by forming a complex with the class  
III phosphatidylinositol 3'-kinase [19,20]. The amount of Beclin 1 protein was reduced by at least 90% 
by the specific siRNA duplex as compared to control siRNA (Figure 2B, left panel). Consistent with 
previous reports, the reduction of Beclin 1 protein suppressed the formation of autophagosomes, as 
demonstrated  by  transmission  electron  microscopy  [13,21]  thus  blocked  the  premature  senescence 
process  induced  by  H2O2  (Figure  2B,  middle  panel).  Subsequent  analysis  of  apoptosis  by  flow 
cytometry  showed  that  Beclin  1  knockdown  evidently  increased  the  number  of  apoptotic  cells  in  
H2O2-treated  cells  as  compared  to  that  in  control  cells  (Figure  2B,  right  panel).  These  data 
demonstrated that autophagy activation protected cells from apoptosis in response to external stress, 
which  likely  was  a  prerequisite  for  cell  senescence  induction,  and  hindered  autophagic  activity 
abolished the induction of premature senescence process under stress conditions. Int. J. Mol. Sci. 2012, 13 
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Figure  2.  Inhibition  of  autophagy  sensitized  cells  to  oxidative  stress.  (A)  First  line: 
inhibition of autophagy with 3-MA was assessed by quantifying the percentage of GFP-LC3 
punctuate structure under fluorescence microscope. GFP fluorescence was examined under 
a  Zeiss  fluorescence  microscope.  Second  line:  cellular  senescence  was  detected  using  
SA-β-gal assay. Third line: quantification of GFP aggregates per cell was performed using 
the ―Analyze particles‖ command in the Image J software. This experiment was done at 
day 4 after treatment with 200 μM H2O2 or constitutively active RasV12 in the presence or 
absence of 1 mM 3-MA. A minimum of 200 cells were scored, and only cells with more 
than five puncta were considered positive. Fourth line: apoptosis was analyzed by Flow 
cytometry analysis. The percentages of Annexin-V positive cells were counted. All values 
were  presented  as  the  mean  ±   S.D.  of  three  independent  experiments.  **  indicated  a 
significant difference at the level of P < 0.01. (B) Left panel: young cells were transfected 
with Beclin 1-specific dsRNA or a scramble dsRNA for 72 h. The efficiency of Beclin 1 
knockdown was confirmed by Western Blot. Middle panel: cells with Beclin 1 knockdown 
were treated with 200 μM H2O2 for 2 h as described in Materials and Methods. At day 4 
after treatment, autophagy was assessed by transmission electron microscopy, the arrows 
indicated typical autophagosomes. Cellular senescence was detected using SA-β-gal assay. 
Right panel: apoptosis was analyzed by flow cytometry as done in (A). 
 Int. J. Mol. Sci. 2012, 13 
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2.3. Increased Autophagy Is Linked to mTOR Inhibition in Senescent Cells 
Inhibition of mTOR (mammalian Target of Rapamycin) is reported as a common event associated 
with autophagy induction [22]. To clarify the molecular mechanisms underlying the observed autophagy 
increase in senescent cells, we first analyzed the status of mTOR signaling pathway in senescent cells. 
mTOR activity was monitored by analyzing the phosphorylation levels of its two main downstream 
targets: 70S6K and 4E-BP1 [23,24]. Phosphorylation of 70S6K at Thr389 has been widely described 
to reflect mTOR activity [25]. Immunoblotting analysis showed that p70S6K level in H2O2-induced 
senescent  cells  was  reduced  prominently  as  compared  with  young  cells  (Figure  3A),  indicating  a  
down-regulation  in  the  activity  of  mTOR.  To  further  confirm  this  observation,  we  analyzed  the 
phosphorylation status of 4E-BP1. Consistent with the observations on 70S6K phosphorylation, we 
detected a clear decrease in the phosphorylation of 4E-BP1 at Thr37/46 in H2O2-induced senescent 
cells (Figure 3A), thus confirming that mTOR activity is down-regulated in senescent cells. Taken 
together, these results demonstrated that the elevation of autophagy activity observed in senescent cells 
was linked to mTOR pathway inhibition.  
2.4. mTOR Inhibition and Increased Autophagy in Senescent Cells Are Linked to AMPK Activation 
We then analyzed the activities of Akt kinase and AMPK kinase, two major kinases controlling 
mTOR activity: The Akt kinase mediates the activation of mTOR in response to growth factors, and 
the AMPK kinase is involved in mTOR activity inhibition in response to nutritional, genotoxic and 
metabolic stress signals [26,27]. We first examined the Akt activity in senescent and control cells. 
Phosphorylation of Akt at Ser473 is often used as an indicator of Akt activity [28]. We found a minimal 
elevation of Akt phosphorylation at Thr308 in H2O2-induced senescent cells as compared with control 
cells (Figure 3B). This suggested that the mTOR pathway inhibition observed in H2O2-induced senescent 
cells is not a consequence of a decrease in the Akt activity. Then, we analyzed the AMPK activity to 
test whether a possible alteration in this kinase could account for the mTOR inhibition observed in 
senescent cells. For that purpose, we first examined the phosphorylation level of AMPK at Thr172, 
which  has  been  widely  used  to  monitor  AMPK  activity  [29].  As  shown  in  Figure  3C,  AMPK 
phosphorylation  was  significantly  higher  in  senescent  cells  than  in  control  cells.  Consequently, 
phosphorylation of ACC, a substrate of AMPK, was also higher in senescent cells than that in control 
cells. This indicated an increase of AMPK activity in H2O2-induced senescent cells. Moreover, we 
analyzed the total protein content of LKB1, the main kinase involved in AMPK phosphorylation, as 
the  cellular  level  of  this  kinase  is  correlated  with  AMPK  activity  [30].  As  shown  in  Figure  3C, 
immunoblotting analysis revealed an appreciable change in the protein levels of LKB1 in senescent 
cells  as  compared  with  control  cells.  Taken  together,  these  results  suggested  that  the  enhanced 
autophagy and mTOR inhibition in H2O2-induced senescent cells were linked to an up-regulation of 
AMPK activity but not to a decrease in Akt activity. Int. J. Mol. Sci. 2012, 13 
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Figure 3. Autophagy increase in senescent cells is linked to the change of AMPK-mTOR 
activity. (A) Immunoblotting analysis of two major mTOR substrates, 70S6K and 4E-BP1, 
in young and H2O2-induced senescent cells. The protein extracted from the harvested cells 
was resolved by SDS-PAGE, transferred to PVDF and probed with the indicated antibodies. 
(B) Immunoblotting analysis of  phosphorylated  Akt and total Akt in  young and H2O2-
induced  senescent  cells.  (C)  Immunoblotting  analysis  of  AMPK  in  young  and  H2O2-
induced senescent cells. Y: young cells; S: H2O2-induced senescent cells. 
 
2.5. AMPK Activation Is Linked to the Increase of AMP: ATP Ratio in Senescent Cells 
To clarify the molecular basis underlying AMPK activation in senescent cells,  we first analyze 
cellular AMP: ATP ratio. As shown in Figure 4A, senescent cells displayed an increased level of AMP 
with a decreased level of ATP. Thus, the ratio of AMP/ATP greatly increased in senescent cells as 
compared with control cells, thereby suggesting that AMPK activation was linked to the increase of 
AMP/ATP ratio in senescent cells.  
Next, we analyzed the transcriptional profiles of genes involved in energy production with mRNA 
microarray analysis to test whether there was an increase of AMP/ATP ratio resulted from the impaired 
energy generation. Comparing senescent cells with control cells, three genes, PDK4, PFKP and FH, 
were expressed at different levels. PDK4 is located in the matrix of the mitochondria and inhibits the 
pyruvate dehydrogenase complex by phosphorylating one of its subunits  [31], thereby inhibits the 
transition (decarboxylation) of glycolysis end product pyruvate to mitochondrial acetyl-CoA, with net 
result of curtailing mitochondrial glucose oxidation. PFKP is a key regulatory enzyme in glycolysis, it 
catalyzes the irreversible conversion of fructose-6-phosphate to fructose-1,6-bisphosphate. FH is an 
enzymatic  component  of  the  tricarboxylic  acid  cycle;  it  catalyzes  the  formation  of  L-malate  from 
fumarate. Among these three genes, PDK4 expression increased in senescent cells as compared with 
that in control cells, whereas PFKP and FH expressions decreased in senescent cells (Figure 4B). The 
altered expression of these enzymes in senescent cells caused the blockage of glycolysis, subsequent 
reduction of ATP production and increase of AMP: ATP ratio in senescent cells.  Int. J. Mol. Sci. 2012, 13 
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Figure 4. AMPK activation is linked to the increase of AMP/ATP ratio in senescent cells. 
(A) ATP and AMP levels in senescent and young cells were quantified by reverse-phase 
HPLC. Data represented as mean ±  S.D. of three independent determinations. * indicated a 
significant difference at the level of P < 0.05, ** indicated a significant difference at the 
level of P < 0.01. (B) Upper panel: changes of the expression of three energy production-
related genes, PDK4, PFKP and FH were analyzed with microarray in senescent cells. 
Lower panel: change of the expression of the three genes was confirmed by real-time PCR. 
Data  represented  as  mean  ±   SD  of  three  independent  experiments.  Y:  young  cells;  S: 
senescent cells. ** indicated a significant difference at the level of P < 0.01. 
 
2.6. FoxO3A Activation Transcriptionally Up-Regulates PDK4 Expression and Contributes to the 
Increase of AMP: ATP Ratio in Senescent Cells 
PDK4 promoter was cloned and analyzed for potential regulatory regions that may be responsible 
for the up-regulation of PDK4 detected in senescent cells. To determine the basal activity of PDK4 
promoter in young and senescent cells, a 1.3-kb PDK4 promoter fused to the luciferase reporter gene 
was  used  in  transient  transfection  studies.  Various  pPDK4  5'-deletion  constructs  were  generated 
(Figure 5A) and transiently co-transfected with a cytomegalovirus-driven Renilla luciferase vector (as 
an internal control) into young and senescent cells. After 36h of incubation, cells were harvested and 
analyzed for luciferase activity. As shown in Figure 5A, luciferase activity induced by the full-length 
PDK4 promoter was approximately 7-fold greater in senescent cells than that in young cells. Deletion 
of segments from the 5' end, from −1300 to −492, slightly reduced the difference in expression between Int. J. Mol. Sci. 2012, 13 
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young and senescent cells. However, further deletion to −144 upstream the transcription starting site of 
the PDK4 promoter greatly reduced the difference in luciferase activity. These data indicated that the 
increased expression of PDK4 in senescent cells required the promoter region from −492 to −144.  
Figure  5.  FoxO3A  transcriptionally  up-regulated  PDK4  expression  in  senescent  cells.  
(A) 5'-deletion analysis of the PDK4 promoter. Various deletion constructs were transiently 
co-transfected with pRL-CMV (as an internal control) into young and senescent cells (left 
panel). The bar graph in the right panel represented the fold difference in luciferase (LUC) 
activity  in  senescent  versus  young  cells  after  normalizing  for  pRL-CMV  activity.  The 
results represented luciferase activity from three independent transfections. The numbers 
represented the positions  relative to  the transcriptional  starting site of the PDK4 gene.  
(B) Mutations of two FoxO binding sites attenuated the fold difference in luciferase (LUC) 
activity in senescent versus young cells. (C) Upper panel: ChIP analysis of in vivo FoxO 
binding in senescent and young cells. Chromatin immunoprecipitation was performed with 
the indicated  antibody,  followed by PCR of the PDK4 promoter region containing the 
consensus FoxO binding site as indicated in (B). Lower panel: Western Blot analysis of 
FoxO3A and FoxO1 expression in  2BS fibroblasts.  Y:  young cells;  S: senescent  cells.  
(D) RNA was prepared at 48 h after LY294002 treatment and real-time PCR was used to 
analyze  PDK4  mRNA  level.  The  values  were  represented  as  the  Mean  ±   SD  of  three 
independent experiments. (E) Young or senescent cells were transiently transfected with a 
synthetic  promoter  containing  three  FoxO3A  response  elements  (FHRE).  Luciferase 
activity was measured 36 h post-transfection. The experiment shown is a representative 
experiment of a minimum of three independent experiments. 
 Int. J. Mol. Sci. 2012, 13 
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To determine the specific transcription factor binding elements within this region, we performed a 
detailed computer analysis using the MatInspector program and found two FoxO transcription factor 
binding elements. Two base mutations within each FoxO element were introduced by site-directed 
mutagenesis in the −492 construct (Figure 5B). We transfected the promoter −492 construct and the 
mutated constructs into young and senescent cells respectively and measured the luciferase activity 
from each construct after normalizing for pRL-CMV control. As shown in Figure 5B, mutation of each 
FoxO  element  lessened  the  difference  in  luciferase  activity;  mutations  of  two  FoxO  elements 
completely eliminated the difference between senescent and young cells. These data suggested that 
FoxO transcription factor contributed to the elevation of PDK4 gene expression in senescent cells. 
Next, ChIP assay was performed to determine whether FoxO could bind to and activate transcription 
from the endogenous
 PDK4 promoter. Interaction between FoxO and the PDK4 promoter region that 
contains the two FoxO binding
 sites was detected by a specific PCR assay of immunoprecipitated
 
FoxO-DNA complexes. Protein-DNA complexes were cross-linked and DNA sheared as described in 
Materials and Methods. FoxO1 antibody was used to immunoprecipitate DNA since it has been shown 
that FoxO1 can regulate PDK4 expression [32]. Results show that no PCR band was detected whether 
in young cells or in senescent cells. However, PCR product was observed in senescent cells but not in 
young cells when FoxO3A antibody was used (Figure 5C). These results showed that FoxO3A, but not 
FoxO1, can bind specifically to the endogenous PDK4 promoter. Further analysis showed that no FoxO1 
expression was detected in 2BS fibroblasts (Figure 5C, Lower panel). This finding could explain the 
observation that no FoxO1 bound to the endogenous PDK4 promoter. Instead, a high level of FoxO3A 
expression was observed in this type of cells (Figure 5C, Lower panel), suggesting that FoxO3A binding 
activated  PDK4  gene  expression  in  senescent  cells.  To  further  confirm  that  FoxO3A  up-regulates 
PDK4 expression, a PI3K-Akt pathway inihibitor, LY294002, was employed. Inhibition of PI3K-Akt 
results in the up-regulation of FoxO3A activity. As shown in Figure 5D, LY294002 treatment of young 
cells  dramatically  increased  PDK4  expression.  Furthermore,  data  showed  that  FoxO3A  activity 
increased in senescent cells compared to young cells (Figure 5E). Taken together, our results indicated 
that FoxO3A was required for the up-regulation of PDK4 expression in senescent cells.  
2.7. Constitutively Active FoxO3A Up-Regulates Autophagy Activity in Young Cells 
Next,  we  test  whether  FoxO3A  activation  up-regulates  autophagy  activity.  Young  cells  were 
infected with pBabe retrovirus expressing constitutively active FoxO3A, which is mutated to alanine at 
all three phosphorylation sites for Akt. Results showed that constitutive active FoxO3A induced PDK4 
basal expression up to 6-fold (Figure 6A). Importantly, expression of active FoxO3A resulted in the 
decreased ATP level (Figure 6B), the increased AMPK activity, the decreased mTOR activity and the 
increased autophagy activity (Figure 6C). It is worth noting that the increase of AMPK activity is not a 
consequence of the up-regulation of LKB1 expression as FoxO3A activation did not change LKB1 
level.  These  data  indicate  that  FoxO3A  may  up-regulate  autophagy  activity  via  blocking 
ATP production. Int. J. Mol. Sci. 2012, 13 
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Figure  6.  FoxO3A  activation  up-regulates  autophagy  activity  in  young  cells.  
FoxO3A-pBABE  and  empty  pBABE  vector  were  packaged  in  pheonix  cells  for  48  h, 
supernatants were collected to infect young 2BS cells. 2BS cells were then maintained in 
puromycin at a concentration of 0.5 μg/mL for 7 days. (A) Real-time PCR detection of 
PDK4 mRNA level in FoxO3A overexpression clones and control clones. (B) Reverse-phase 
HPLC analysis of ATP concentration in FoxO3A overexpression clones and control clones. 
(C) Total and phosphorylated AMPK, 70S6K phosphorylation and LC3 protein level by 
western blot analysis in FoxO3A overexpression clones and control clones. 
 
2.8. Knockdown of FoxO3A Inhibits Autophagy Activity in Senescent Process 
Finally, we tested whether the knockdown of FoxO3A inhibits autophagy activation in senescent 
process. For this purpose, RNA interference was used to deplete FoxO3A protein. The amount of 
FoxO3A protein in the cells was reduced by at least 90% by the specific siRNA duplex as compared to 
control siRNA (Figure 7A). Subsequently, cells with FoxO3A or control siRNA treatment were induced 
to senescence by H2O2. Four days after H2O2 exposure, autophagy activity was assayed by examining 
LC-3  protein  expression.  As  shown  in  Figure  7B,  FoxO3A  siRNA  treatment  inhibited  autophagy 
activity compared with control. Consistent with the cytoprotective function of autophagy in senescent 
cells, the knockdown of FoxO3A promoted cell apoptosis in senescent process as judged by caspase-3 
activity (Figure 7C) and the number of cell death (Figure 7D). These data indicate that FoxO3A is 
required for autophagy activation in senescent process. Int. J. Mol. Sci. 2012, 13 
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Figure  7.  Knockdown  of  FoxO3A  inhibits  autophagy  activity  in  senescent  process.  
(A)  Confirmation  of  FoxO3A  knockdown  by  RNA  interference  in  young  cells.  
(B) Semiquantitative analysis of the expression of LC3 by immunoblotting four days after 
H2O2 treatment. Densitometry was performed for quantification (LC3-II/actin). (C) DEVDase 
activity was measured four days after H2O2 treatment. (D) Cell morphology four days after 
H2O2 treatment and cell death was determined by Trypan blue exclusion test. Data were 
expressed as the percentage of dead cells relative to total cells. The values are represented 
as the mean ±  SD of three independent experiments.  
 
3. Discussion 
Our results demonstrated that autophagy plays a cyto-protective role in senescent cells. This is 
supported  by  following  observations:  autophagy  activity  increased  in  senescent  cells  compared  to 
young cells; inhibiting autophagy caused the increase of cell death and hindered senescence process in 
the course of senescence induction; the cyto-protective role of autophagy is consistent with its effect 
on lifespan extension.  
Transcription factor FoxO has been shown to regulate autophagy activity, but the mechanism is 
poorly understood. Several reports demonstrated that FoxO negatively controls mTOR signaling in 
various organisms. For example, in C.elegans Daf-16 (FoxO) negatively regulates the expression of 
Daf-15  (Raptor)  [33],  and  in  skeletal  muscle  FoxO1  down-regulates  mTOR,  Raptor  and  other 
components of the mTOR signaling pathway [34,35]. In addition, recent two reports showed that in 
muscle atrophy, FoxO3A activates autophagy via transcriptionally regulating the expression of many 
autophagy-related genes, including LC3B, Bnip3 and Bnip3L [36,37]. In the present study, we found 
that  FoxO3A  regulated  autophagy  activity  through  a  new  pathway  in  senescent  cells.  FoxO3A 
activation  in  senescent  cells  inhibits  glucose  catabolism  by  transcriptionally  up-regulating  the 
expression  of  PDK4,  blocking  ATP  generation,  hence  causing  the  AMPK  activation  and  mTOR Int. J. Mol. Sci. 2012, 13 
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inhibition that results in the increase of autophagy activity in senescent cells. These findings suggested 
a novel mechanism by which FoxO3A factors can activate autophagy. 
FoxO3A activity is regulated primarily by post-translational modifications, including phosphorylation, 
acetylation and ubiquitination, which depend on environmental stimuli [38]. In mitogenic conditions, 
Akt  is  a  primary  regulator  of  FoxO3A.  Upon  activation  following  mitogenic  stimulation,  Akt 
translocates to the nucleus and phosphorylates FoxO3A, decreasing FoxO3A activity. Data from our 
and other studies showed that Akt activity increased in H2O2-induced senescent cells [39]; however, 
we found that FoxO3A activity did not decrease but did increase in H2O2-induced senescent cells. 
There are two possible explanations for the inconsistency between Akt activity and FoxO3A activity: 
(1)  the  increase  of  FoxO3A  activity  is  likely  resulted  from  the  change  of  other  post-translational 
modification; (2) nuclear translocation of Akt is impaired in H2O2-induced senescent cells.  
The increase of FoxO3A activity is also observed in Raf-induced senescent cells and replicative 
senescent cells [40,41], but the significance of FoxO3A activation in senescent cells is unknown. It has 
been shown that FoxO3A contributes to age-related decline in tissue function by increasing proteolysis 
of matrix components via up-regulation of collagenase expression [41]. In this study, we showed that 
FoxO3A activation protects cells from apoptosis in senescence process; this is achieved, at least partly, 
by up-regulating autophagy activity. It has been well known that activated FoxO protein may promote 
stress resistance by binding to the promoter of the genes encoding manganese superoxide dismutase 
(MnSOD) and catalase, two scavenger proteins that play essential roles in oxidative detoxification in 
mammals [42]. Therefore, it cannot be ruled out that this pathway contributes to the cyto-protective 
function of FoxO3A in senescence process. 
Taken  together,  our  results  indicated  that  the  autophagy  activity  increased  in  senescent  cells. 
Inhibiting autophagy may cause the increase of cell death, suggesting that autophagy activation plays a 
protective role in senescent cells. Furthermore, analysis of the mechanism underlying the increase of 
autophagy activity in senescent cells showed that FoxO3A contributes to AMPK activation and mTOR 
inhibition through blocking glucose catabolism and subsequent ATP production. However, it cannot be 
ruled out that other pathways are involved in the increase of autophagy activity in senescent cells. 
4. Materials and Methods 
4.1. Materials 
3-methyladenine (3-MA) and monodansylcadaverine (MDC) were purchased from Sigma Chemical 
Co. (St. Louis, MO, USA). Antibody against microtubule-associated protein 1 light chain 3 (LC-3) was 
also purchased from Sigma. Antibodies against p70S6K (Thr389), p4E-BP1 (Thr37/46), pAkt (Thr308), 
pTSC2 (Thr1462), pAMPK-α (Thr172), LKB1 and pACC (Ser79) were purchased from Cell Signaling 
Technology, Inc. (Beverly, MA, USA). Antibodies against Beclin 1 and β-actin were obtained from 
Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
4.2. Cell Culture 
Human  embryonic  lung  diploid  fibroblast  2BS  cells  (obtained  from  the  National  Institute  of 
Biological Products, Beijing, China) were previously isolated from female fetal lung fibroblast tissue Int. J. Mol. Sci. 2012, 13 
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and have been fully characterized [11]. The cells were maintained in Dulbecco’s modified Eagle’s 
medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% (v/v) fetal bovine serum (Invitrogen), 
glutamine (2 mM; Invitrogen) and penicillin/streptomycin (100 units/mL/100 µg/mL; Invitrogen) at  
37 C in 5% CO2. Cells at early passages (between 16 and 25 passages) were used in all experiments to 
avoid complications of replicative senescence as 2BS cells have a mean life span about 55–70 passages. 
For the induction of premature senescence, 2BS cells at about 75% confluence were briefly exposed to 
200 μM H2O2 (diluted in Dulbecco’s Modified Eagle’s medium supplemented with 10% FBS) for 2 h. 
The cells were washed twice with Dulbecco’s Modified Eagle’s medium (DMEM) to remove H2O2 
and re-cultured in fresh complete medium. Cell senescent phenotype was determined by SA-β-gal 
staining, cell proliferation and morphology at 3–5 days after H2O2 treatment. 
4.3. Labeling of Autophagic Structures with MDC 
2BS cells growing on coverslips were incubated with 0.05 mM MDC added directly to the culture 
medium. After incubation at 37 °C  for 1 h, the cells were fixed in 4% paraformaldehyde for 15 min 
and immediately analyzed using a Zeiss epifluorescence microscope (Germany) with excitation and 
emission at 380 nm and 525 nm wavelength, respectively. 
4.4. Electron Microscopy 
The  cells  were  harvested  by  trypsinization,  washed  twice  with  PBS  and  fixed  with  ice-cold 
glutaraldehyde (3% in 0.1 M cacodylate buffer, pH 7.4) for 30 min. After washing in PBS the cells 
were  post-fixed  in  OsO4  and  embedded  in  Epon;  0.1  mm  thin  sections  were  stained  with  uranyl 
acetate/lead  citrate  (Sigma-Aldrich,  St.  Louis,  MO,  USA)  and  viewed  by  a  JEM1230  electron 
microscope (Japan). 
4.5. Immunoblotting 
Cells pellets were lysed in Triton X-100/glycerol lysis buffer plus 1% sodium deoxycholate and 
0.1% SDS, and then electrophoresed and transferred onto nitrocellulose membranes. After blocking 
with 5% non-fat dry milk, the membranes were incubated with the primary antibodies at 1:1000 dilution 
overnight at 4 °C  followed by the secondary antibodies conjugated with horseradish peroxidase at 
1:5000  dilution  for  2  h  at  room  temperature.  Protein  bands  were  visualized  on  X-ray  film  using  
an  enhanced  chemiluminescence  system  (Pierce  Biotechnology),  and  quantitatively  analyzed  
via densitometry.  
4.6. Flow Cytometry 
The cells were trypsinized, washed with PBS twice, and then adjusted to 5 ×  10
5 cells/500 μL in the 
binding buffer prior to incubation with Annexin V-fluorescein isothiocyanate (FITC) and propidium 
iodide (PI) according to the instructions of an Annexin-V-FITC Apoptosis Detection Kit (Biovision 
Inc, Mountain View CA) and finally analyzed by flow cytometry (FACS Aria, Becton Dickinson). All 
the floating cells were harvested for apoptotic analysis. Int. J. Mol. Sci. 2012, 13 
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4.7. Caspase-3 Activity Assay 
Caspase-3 Cellular Activity Assay Kit PLUS (AK-703) (Biomol, Germany) was used. The assay is 
based  on  the  cleavage  of  the  specific  fluorogenic  peptide  substrate  acetyl-aspartyl-glutamyl-valyl-
aspartyl-7-amino-4-trifluoromethylcoumarin  (Ac-DEVD-AFC)  for  caspase-3-like  activity.  Sample 
cells were harvested at various time points post-treatment and treated according to the manufacturer’s 
instruction. Fluorescence of AFC, which was proportional to the DEVD-ase activity in the cell lysates, 
was recorded on fluoroscan Ascent FL (Labsystems, Finland) at an excitation/emission wavelength of 
390/510 nm, respectively. 
4.8. Microarray Analysis 
RNAs of young (22 PD) and senescent (61 PD) fibroblasts were extracted using Trizol Reagent 
(Invitrogen). The samples (preserved in DEPC water and transferred with dry ice) were then sent to 
CapitalBio Technology, Co., Ltd. for the detection of genes differently expressed between young and 
senescent  cells.  The  product  No.  of  gene  chip  used  was  220,010,  Jingxin  human  whole  genome 
oligonucleotide microarray V1.0 with 22,000 probes.  
4.9. SA-β-gal Staining 
For detection of SA-β-gal activity, cells were washed twice with phosphate-buffered saline (PBS, 
pH 7.2), fixed with 4% formaldehyde for 5 min at 22 °C , and washed with PBS (pH 6.0) again. Cells 
were then incubated overnight at 37 °C  without CO2 in freshly prepared staining buffer (1 mg/mL  
X-gal, 40 mM citric acid/sodium phosphate, pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium 
ferricyanide, 150 mM NaCl, 2 mM MgCl2). 
4.10. siRNA Transfection 
The cells were seeded at 40% confluence per well in 6 well plates overnight and transfected with 
Beclin 1 siRNA or FoxO3A siRNA or control siRNA duplex (Santa Cruz Biotechnology, CA, USA) 
using Lipofectamine 2000. Successful targeted knockdown was verified by Western Blot.  
4.11. Plasmid Construct 
To  obtain  various  deletion  constructs  of  human  PDK4  promoter  plasmids,  a  series  of  forward 
primers and a common reverse primer were used to amplify the PDK4 promoter fragments by PCR 
from human genomic DNA. The various forward primers were used: −1300，5'-AA CTC GAG CGA 
GGT TGC AGT GAG CCG AGA TG-3'; −492, 5'-AA CTC GAG TGT GCC GGT CTC TTC TGA 
AGA AAA G-3'; −144, 5'-AA CTC GAG CTT CCC ACC CTT TTT CCG TCA-3'; (the underlined 
sequence is the Xho I (NEB, Beverly, MA, USA) recognition site). The common reverse primer: +69, 
5'-AA AAG CTT CCG CCG CCG CCC GAG GTT TTA-3' (the underlined sequence is the HindIII 
(NEB) recognition site). Each pair of primers was used to amplify various sizes of promoter region. 
The resulting fragments were subjected to restriction digestion and subcloned into pGL3-basic plasmid Int. J. Mol. Sci. 2012, 13 
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(Promega, Madison, WI, USA). These clones were designated as −1300 (full-length), −492,  −144 
relative to the transcriptional start site.  
4.12. Transient Transfection and Luciferase Assay 
For  PDK4  promoter  luciferase  assay,  pGL3-PDK4  and  pRL-CMV  (Promega)  were  transiently 
transfected into 2BS cells using Lipofectamine 2000 transfection reagent. After 36 h of incubation, 
cells  were  lysed  in  passive  lysis  buffer  (Promega),  and  luciferase  activity  was  measured  using 
Luciferase Assay System (Promega) with a luminometer (Lumat LB 9501; Berthold). 
4.13. Site-Directed Mutagenesis 
Bases were mutated using the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, 
California, USA).  Two  promoter  mutagenic primers  were used (primer1 for FoxO binding site 1:  
5'-CGC AGG TCT TTA GGT ACT TTA TTC CTT TCT CT-3'; primer2 for FoxO binding site 2:  
5'-ACA GCC TCC GAG TTG AGA ACA AGG GCG AGC CT-3'. The underlined bases are the 
mutated bases) were synthesized. Pfu Turbo DNA polymerase was used to synthesize the mutagenic 
promoter  and  3'UTR,  followed  by  digestion  of  the  parental  plasmids  by  DpnI  according  to  the 
manufacturer’s instructions. The mutated plasmid was transformed into XL1-Blue competent cells and 
the resulting plasmid was isolated and sequenced to confirm the mutations. 
4.14. Chromatin Immunoprecipitation 
Chromatin immunoprecipitations were performed using the Chromatin Immunoprecipitation Assay 
Kit  (Upstate). Antibodies  used  for ChIP  were  anti-  FoxO3A. Primer pairs used  for PCR were  as 
following: FoxO binding site 1 (−439 to −420), forward primer 5'-GAA GAA AAG GGG GCG GTG 
GG-3' and reverse primer 5'-GCC AAC AAG CTG CGT TCA AAA GT-3'. FoxO binding site 2 (−268 
to −249), forward primer 5'-CTC TGA GCA AGG ACC AAT GAG CA-3' and reverse primer 5'-TGG 
GGC AAC GTG GGC TTA AGA TT-3'. 
4.15. Nucleotide Extraction and AMP/ATP Analysis 
Cells  were  washed  twice  with  ice-cold  PBS.  Thereafter,  cells  were  harvested  by  trypsinization 
followed by centrifugation at 3000 g for 10 min at 4 °C . Cell pellets were then washed in ice-cold 
DMEM and centrifugated at 10,000 g for 10 min. Cells were lysed by the addition of trichloroacetic acid 
(0.73 M, final concentration), vortexed and then incubated on ice for 2 min. The resulting suspension 
was cleared by centrifugation at 15,000 g for 2 min. An aliquot of the supernatant was neutralized with 
ice-cold KOH. Total cellular AMP and ATP were quantified by reverse-phase HPLC of trichloroacetic 
acid  extracts  using  a  Vydac  C18  reverse-phase  column.  Protein  concentration  was  determined  
spectro-photometrically using the BCA protein assay kit. 
4.16. Real-Time PCR 
Total RNA was extracted using Trizol reagent (Invitrogen Corp) according to the manufacturer’s 
protocol. The first strand cDNA was synthesized with SuperScript III (Invitrogen Corp), and PDK4, Int. J. Mol. Sci. 2012, 13 
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PFKP and FH mRNAs were analyzed by real-time PCR with the following primers: PDK4: forward 
primer 5'-GGT TAT TGT TGT CTT GGG AAA-3', reverse primer 5'-CTT TGC ATA CAG ACG 
AGA AAT-3'. PFKP: forward primer 5'-CTT TGG ATG GGC TTG GGA T-3', reverse primer 5'-TGC 
TGG GGT TAC AGG TGT G-3'. FH: forward primer 5'-TCA GTG TGA AGC AAT GAC CA-3', 
reverse  primer  5'-AAC  TGA  AGC  ATC  CCC  CAG  CA-3').  The  GAPDH  primers  were:  forward 
primer 5'-AGA AGG CTG GGG CTC ATT TG-3' and reverse primer 5'-AGG GGC CAT CCA CAG 
TCT TC-3'. 
4.17. Statistical Analysis 
All experiments were repeated three times and similar results were obtained. Statistical analysis of 
the  difference  between  groups  was  performed  using  Student’s  t-test.  Significance  was  established 
when P < 0.05. 
5. Conclusions  
We have demonstrated that the activity of autophagy increases in H2O2 or RasV12-induced senescent 
fibroblasts. Inhibiting autophagy promotes cell apoptosis in senescent cells, suggesting that autophagy 
activation plays a cytoprotective role. Furthermore, our data indicate that the increase of autophagy in 
senescent cells is linked to the activation of transcription factor FoxO3A, which blocks ATP generation 
by transcriptionally up-regulating the expression of PDK4, an inhibitor of pyruvate dehydrogenase 
complex, thus leading to AMPK activation and mTOR inhibition. These findings suggest  a novel 
mechanism by which FoxO3A factors can activate autophagy via metabolic alteration. 
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